Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Dang Amit"'
Publikováno v:
Annals of Cardiac Anaesthesia, Vol 12, Iss 2, Pp 170-171 (2009)
Externí odkaz:
https://doaj.org/article/e98e2a8eedd94bb796434c42918090eb
Autor:
Dang, Amit, Sharma, Jitendar
Publikováno v:
In Value in Health Regional Issues May 2020 21:100-104
Publikováno v:
Indian Journal of Medical Research. Jan2023, Vol. 157 Issue 1, Following p11-21. 14p.
Publikováno v:
In Value in Health Regional Issues May 2016 9:78-83
Real world safety of bevacizumab in cancer patients: A systematic literature review of case reports.
Autor:
Dang, Amit1 amit.d@marksmanhealthcare.com, Jagan Mohan Venkateswara Rao, P.2 jagan.v@marksmanhealthcare.com, Kishore, Ravi2 ravikishore.h@marksmanhealthcare.com, Vallish, B.N.3 vallish.bn@marksmanhealthcare.com
Publikováno v:
International Journal of Risk & Safety in Medicine. 2021, Vol. 32 Issue 3, p163-173. 11p.
Publikováno v:
Journal of Family Medicine & Primary Care. May2020, Vol. 9 Issue 5, p2207-2213. 7p.
This scoping literature review will explore the efficacy and safety of ivermectin and doxycycline when used as monotherapy and as combination for treating confirmed cases of COVID-19.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::046537453e59312505d4c6d457df9902
With an improvement in the realisation of the importance of collecting patient-reported outcomes (PROs), sponsors of randomized controlled trials (RCTs) around the world have started incorporating questions related to Quality of Life (QoL) and other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6beb835b3816300b6d63e97706dde8b5
Autor:
BN, Vallish, Dang, Amit
Hydroxychloroquine (HCQ) has recently gained significant interest across the world for its possible role as an antiviral drug against the SARS-CoV2 in the fight against COVID-19. HCQ is a derivative of the antimalarial drug chloroquine, and is used f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a56eec781fc96b5c428e62985b28980e